{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:06:44Z","timestamp":1784830004025,"version":"3.55.0"},"reference-count":30,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2026,7,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) infection is a major cause of cervical, anal and oropharyngeal cancers. Although Korea has implemented a national HPV vaccination programme since 2016, nationwide evidence on incidence trends and medical costs of HPV-related diseases remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective population-based study analysed Korean National Health Insurance Service claims data. Age-standardised incidence (ASI) rates of cervical intraepithelial neoplasia (CIN1 and CIN2\/3), genital warts (GWs), and cervical, oropharyngeal and anal cancers from 2015 to 2022 were calculated using the 2022 Korean population as the standard. Trends in ASI were analysed using Joinpoint regression with a piecewise log-linear (Poisson) model. For diseases with and without statistically significant Joinpoints, trends were reported using pre-identified and post-identified segment-specific annual percentage changes (APCs) and the average annual percentage change (AAPC), respectively. Trends in total medical costs from 2015 to 2021 were evaluated using linear regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ASI trends differed by sex and disease type. Cervical cancer incidence among females declined significantly during 2015\u20132022 (AAPC; \u22124.2%, p&lt;0.001). Joinpoint regression identified significant inflection points in 2019 for both female and male GWs. Female GW incidence increased during 2015\u20132019 (APC; 3.7%, p=0.010) and then decreased significantly during 2019\u20132022 (APC; \u221214.0%, p&lt;0.001). Male GW incidence increased significantly during 2015\u20132019 (APC; 11.3%, p&lt;0.001) and then showed no statistically significant change during 2019\u20132022 (APC; 1.4%, p=0.290).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These descriptive findings provide population-level evidence on HPV-associated disease burden in Korea but cannot establish causal attribution to vaccination, screening or other preventive interventions, necessitating continued surveillance with individual-level data linkage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/sextrans-2026-056914","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:20:29Z","timestamp":1784827229000},"page":"sextrans-2026-056914","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in incidence and medical costs of human papillomavirus\u2013related diseases in Korea: evidence from National Health Insurance claims"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3734-6594","authenticated-orcid":false,"given":"Ji-Eun","family":"An","sequence":"first","affiliation":[{"name":"College of pharmacy, Kangwon National University, Chuncheon-si, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5136-6764","authenticated-orcid":false,"given":"Chelim","family":"Cheong","sequence":"additional","affiliation":[{"name":"Department of Health Administration, Kongju National University, Gongju-si, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-0714","authenticated-orcid":false,"given":"Junwoo","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Statistics, Kyungpook National University, Daegu, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5488-5068","authenticated-orcid":false,"given":"Su-Yeon","family":"Yu","sequence":"additional","affiliation":[{"name":"College of pharmacy, Kangwon National University, Chuncheon-si, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2026072310202072000_sextrans-2026-056914v1.1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30716"},{"key":"2026072310202072000_sextrans-2026-056914v1.2","doi-asserted-by":"publisher","DOI":"10.1002\/path.4424"},{"key":"2026072310202072000_sextrans-2026-056914v1.3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw354"},{"key":"2026072310202072000_sextrans-2026-056914v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.089"},{"key":"2026072310202072000_sextrans-2026-056914v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq001"},{"key":"2026072310202072000_sextrans-2026-056914v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00603-7"},{"key":"2026072310202072000_sextrans-2026-056914v1.7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt053"},{"key":"2026072310202072000_sextrans-2026-056914v1.8","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1016\/j.vaccine.2018.06.046","article-title":"The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015","volume":"36","author":"Ki","year":"2018","journal-title":"Vaccine"},{"key":"2026072310202072000_sextrans-2026-056914v1.9","unstructured":"National HPV vaccination for 12-year-old male adolescents begins in May: free HPV vaccination for boys [Internet]. Cheongju: Korea Disease Control and Prevention Agency, Available: https:\/\/www.kdca.go.kr\/kdca\/2848\/subview.do?enc=Zm5jdDF8QEB8JTJGYmJzJTJGa2RjYSUyRjQyJTJGMzEwOTQ3JTJGYXJ0Y2xWaWV3LmRvJTNG"},{"key":"2026072310202072000_sextrans-2026-056914v1.10","unstructured":"Social Indicators of Korea . Health insurance coverage rate [Internet].Available: https:\/\/www.index.go.kr\/unity\/potal\/indicator\/IndexInfo.do?clasCd=10&idxCd=F0072"},{"key":"2026072310202072000_sextrans-2026-056914v1.11","unstructured":"Joinpoint Trend Analysis Software [Internet]. n.d. Available: https:\/\/surveillance.cancer.gov\/joinpoint\/"},{"key":"2026072310202072000_sextrans-2026-056914v1.12","unstructured":"A plan for the promotion of the national cancer management project in 1999 [Internet]. n.d. Available: https:\/\/www.mohw.go.kr\/board.es?mid=a10503010300&bid=0027&act=view&list_no=18319&tag=&nPage=1539"},{"key":"2026072310202072000_sextrans-2026-056914v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.290"},{"key":"2026072310202072000_sextrans-2026-056914v1.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2968","article-title":"Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data","volume":"339","author":"Sasieni","year":"2009","journal-title":"BMJ"},{"key":"2026072310202072000_sextrans-2026-056914v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)02178-4"},{"key":"2026072310202072000_sextrans-2026-056914v1.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185332","article-title":"Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia","volume":"13","author":"Hall","year":"2018","journal-title":"PLoS One"},{"key":"2026072310202072000_sextrans-2026-056914v1.17","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2024040","article-title":"Effect of the human papillomavirus vaccine on the risk of genital warts: a nationwide cohort study of Korean adolescent girls","volume":"46","author":"Cho","year":"2024","journal-title":"Epidemiol Health"},{"key":"2026072310202072000_sextrans-2026-056914v1.18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"The Lancet"},{"key":"2026072310202072000_sextrans-2026-056914v1.19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30035"},{"key":"2026072310202072000_sextrans-2026-056914v1.20","unstructured":"HPV 12-year-old vaccination status [Internet]. n.d. Available: https:\/\/nip.kdca.go.kr\/irhp\/infm\/goVcntInfo.do?menuLv=1&menuCd=132"},{"key":"2026072310202072000_sextrans-2026-056914v1.21","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2468-2667(16)30001-9","article-title":"Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models","volume":"1","author":"Brisson","year":"2016","journal-title":"Lancet Public Health"},{"key":"2026072310202072000_sextrans-2026-056914v1.22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2025.03.008","article-title":"Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies","volume":"195","author":"de Bondt","year":"2025","journal-title":"Gynecol Oncol"},{"key":"2026072310202072000_sextrans-2026-056914v1.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077341","article-title":"Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study","volume":"385","author":"Falcaro","year":"2024","journal-title":"BMJ"},{"key":"2026072310202072000_sextrans-2026-056914v1.24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15585\/mmwr.mm7406a4","article-title":"Trends in cervical precancers identified through population-based surveillance - Human Papillomavirus Vaccine Impact Monitoring Project, five sites, United States, 2008\u20132022","volume":"74","author":"Gargano","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026072310202072000_sextrans-2026-056914v1.25","doi-asserted-by":"crossref","first-page":"107363","DOI":"10.1016\/j.ijid.2024.107363","article-title":"Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16\/18 infections and CIN2+ in women: a systematic review and network meta-analysis","volume":"151","author":"Wu","year":"2025","journal-title":"Int J Infect Dis"},{"key":"2026072310202072000_sextrans-2026-056914v1.26","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.833048","article-title":"Positive rate of human papillomavirus and its trend in head and neck cancer in South Korea","volume":"8","author":"Jun","year":"2021","journal-title":"Front Surg"},{"key":"2026072310202072000_sextrans-2026-056914v1.27","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.vaccine.2023.08.047","article-title":"Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer","volume":"41","author":"Reuschenbach","year":"2023","journal-title":"Vaccine"},{"key":"2026072310202072000_sextrans-2026-056914v1.28","unstructured":"HPV-associated cancer diagnosis by age [Internet]. n.d. Available: https:\/\/www.cdc.gov\/cancer\/hpv\/diagnosis-by-age.html?utm_source"},{"key":"2026072310202072000_sextrans-2026-056914v1.29","unstructured":"HPV\u2019s economic burden: unmasking the benefits of HPV prevention [Internet]. n.d. Available: https:\/\/a.storyblok.com\/f\/148610\/x\/94beefee2f\/global-report-hpv_2025-04-22.pdf"},{"key":"2026072310202072000_sextrans-2026-056914v1.30","article-title":"The road to recovery: impact of COVID-19 on healthcare utilization in South Korea in 2016-2022 using an interrupted time-series analysis","volume":"41","author":"Yoo","year":"2023","journal-title":"Lancet Reg Health West Pac"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2026-056914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:20:32Z","timestamp":1784827232000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2026-056914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":30,"alternative-id":["10.1136\/sextrans-2026-056914"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2026-056914","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}